Home>Topics>>Incyte's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Incyte's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Healthcare Sector and Stocks Analysis from Seeking Alpha
Thu, 14 Feb 2013
Incyte Corporation ( INCY ) Q4 2012 Earnings Call February 14, 2013 8:30 am ET Executives Pamela Murphy - VP, IR & Corporate Communications Paul Friedman - President & CEO Jim Daly - EVP & CCO Dave Hastings - EVP & CFO Rich Levy - EVP, Chief Drug Development & Medical Officer Analysts Matt Roden - ...